Patents Assigned to BEIJING BETTERMAB BIOTECHNOLOGY CO., LTD
  • Anti-human IL-17 monoclonal antibodies and use thereof
    Patent number: 10392436
    Abstract: The present application discloses a novel anti-human IL-17 monoclonal antibody obtained by phage antibody library screening and genetic engineering, or a functional fragment thereof, a polynucleotide encoding the monoclonal antibody or the functional fragment thereof, a vector comprising the polynucleotide, a host cell comprising the polynucleotide or vector, a method for preparing and purifying the antibody, and use of the antibody or the functional fragment thereof.
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: August 27, 2019
    Assignees: BEIJING BETTERMAB BIOTECHNOLOGY CO., LTD, BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD, GENRIX (SHANGHAI) BIOPHARMACEUTICAL CO. LTD., CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD.
    Inventors: Zhigang Liu, Shijie Shen, Yulan Liu, Jingjing Guo, Xiaobo Hao